Selling a Medical Practice in 2026: Valuation, Buyers, and What the Process Actually Looks Like

Most physicians spend 20 to 30 years building a practice and about six months selling it. That imbalance creates problems. The valuation frameworks are unfamiliar. The buyer landscape has shifted dramatically since 2020. And the structural decisions made at the letter-of-intent stage — asset vs. stock sale, earnout terms, post-closing employment — can move the net proceeds to you by hundreds of thousands of dollars in either direction.

This guide is written for the physician or practice administrator who is 12 to 36 months from a transaction and wants to understand the mechanics before entering a process. We cover how practices are valued (all three methods), who the buyers are and what each type actually wants, the tax structure decision, what drives premium pricing, and the most common mistakes that erode value or collapse deals entirely.

Why Physicians Are Selling — and Why Timing Matters

The motivations behind practice sales fall into a few consistent patterns: retirement (the most common driver), burnout and administrative fatigue, partnership disputes, the desire to monetize while valuations remain reasonable, and the recognition that competing as an independent practice is getting harder in payer-saturated markets.

What many sellers don't appreciate is that timing relative to practice performance matters significantly. Buyers value trailing EBITDA (earnings before interest, taxes, depreciation, and amortization), typically using a weighted average of the last two or three years. If your collections have declined — because a physician left, because you lost a major payer contract, or because volume dropped during a renovation — your trailing numbers look weak even if the practice is fundamentally healthy.

The best time to begin a sale process is after two or three consecutive strong years, with collections trending upward, your physician roster stable, and no major payer contracts up for renewal in the near term. Preparing 18 to 24 months in advance gives you time to clean up the financials, address any compliance gaps, and approach the market from strength rather than necessity.

What You're Actually Selling

Practice buyers are not buying a building or a list of equipment. They are buying a cash flow stream, and everything they evaluate is in service of understanding that stream — its size, its stability, and its growth trajectory.

The tangible assets — accounts receivable, equipment, EHR systems, leasehold improvements — typically represent a fraction of total deal value in physician practice transactions. What drives value is the intangible layer: the payer contracts (particularly any favorable fee schedules that took years to negotiate), the patient panel and retention rates, the referring physician relationships, the staff (particularly experienced billing and clinical staff), and the practice's reputation in the local market.

This is why a three-physician internal medicine practice with $3.2 million in collections, strong patient retention, and a stable employed mid-level team can sell for more than a five-physician practice with $4 million in collections but high associate turnover, a payer mix dominated by Medicaid, and a lease expiring in 18 months. Cash flow size is one input, not the whole answer.

The Three Valuation Methods Explained

Healthcare practice valuations use three primary methodologies. Most sophisticated buyers triangulate across all three rather than relying on any single approach.

1. Revenue Multiple (the simplest method)

A revenue multiple applies a multiplier to the practice's annual collections. It's the fastest way to benchmark value and the method most often quoted in informal conversations. However, it ignores profitability entirely — two practices with identical collections but different overhead structures can have dramatically different real values.

Revenue multiples are most useful as a sanity check or for practices where EBITDA analysis is difficult (for example, a solo physician who pays herself well above market rate, making EBITDA artificially low). The range is typically 0.4x to 2.0x annual collections, with the wide spread driven by specialty, geographic market, payer mix, and buyer type.

2. EBITDA Multiple (the standard for larger practices)

EBITDA-based valuations calculate the practice's earnings before interest, taxes, depreciation, and amortization — then apply a multiple. For physician practices, the EBITDA calculation almost always includes an adjustment: the physician owner's compensation is replaced with a market-rate locum tenens equivalent (typically $200,000–$350,000 depending on specialty), producing what's called "adjusted EBITDA" or "provider-neutral EBITDA."

This normalization is important. A solo ophthalmologist paying herself $850,000 in a highly profitable practice is not really generating $850,000 in EBITDA — the replacement cost of her clinical labor is a real expense that any buyer will incur. Stripping out her actual comp and replacing it with a market-rate equivalent gives a more accurate picture of practice economics.

EBITDA multiples range from 3x to 14x depending heavily on practice size (larger is better), buyer type (PE pays more), specialty (higher-margin specialties command higher multiples), and market dynamics.

3. Asset-Based Valuation

Asset-based approaches value the tangible assets of the practice: equipment (at depreciated or appraised fair market value), accounts receivable (typically discounted for collectability), supplies, and leasehold improvements. This method produces the floor value — what the practice is worth if you simply liquidate it — and is rarely the operative valuation method in going-concern transactions. It becomes relevant when practices are losing money and the buyer is acquiring assets rather than cash flow.

Valuation Multiples by Specialty (2025–2026)

Multiples vary substantially by specialty, driven by procedural margins, payer mix, scalability, and buyer appetite. The table below reflects market data from recent transactions. Note that these are ranges — where your practice falls within the range depends on size, performance, and buyer type.

Who's Buying: Hospital Systems, PE, and Independent Physicians

The buyer you choose — or who finds you — shapes the economics, the post-closing employment terms, and what happens to your practice culture. Each buyer type has fundamentally different motivations.

Hospital Systems and Health Systems

Hospitals acquire practices primarily for strategic reasons: patient referral capture, market share defense, employed physician alignment, and value-based care infrastructure. They are not looking to maximize EBITDA extraction — they expect to subsidize physician compensation above what the practice earns because the downstream revenue (inpatient admissions, imaging, surgical cases) justifies the investment.

This means hospital offers are often structured differently from PE offers. The purchase price may be lower on paper, but post-closing compensation is typically above what you were paying yourself, and the employment agreement carries greater security. The tradeoffs: administrative autonomy decreases significantly, employment contracts are typically two to five years with restrictive covenants, and the bureaucratic decision-making pace of a large health system can be frustrating for practice owners accustomed to moving quickly.

Hospital transactions are also typically asset purchases structured to satisfy tax-exempt status requirements (hospitals cannot pay more than fair market value for a practice, creating a ceiling on purchase price that does not apply to PE buyers).

Private Equity-Backed Platforms

PE buyers are financial buyers. They acquire practices, consolidate them into larger platforms, drive margin improvement through operational standardization and group purchasing leverage, and exit to a strategic buyer or larger PE fund in five to seven years. The exit multiple arbitrage — buying individual practices at lower multiples, selling the consolidated platform at a higher multiple — is the core of the PE value creation thesis.

For sellers, PE offers several potential advantages: higher headline purchase prices than hospital systems (because PE is not constrained by fair market value), rollover equity that gives you upside in the platform, and often more preserved clinical autonomy than hospital employment. The risks are real, though: if the platform underperforms, your rollover equity is worth less or nothing; post-close cost reduction may affect your staff or operations; and the eventual exit may involve another transaction you didn't anticipate.

Rollover equity explained: PE buyers typically ask physicians to roll over 10–30% of their transaction proceeds into equity in the acquiring platform. If you receive a $3 million offer and are asked to roll over 20%, you receive $2.4 million at close and hold $600,000 in platform equity. If the platform achieves a successful exit at a higher multiple, that equity could double or triple. If not, it may be worth far less. Rollover equity is not a gift — it is a risk-sharing mechanism that aligns your interests with the PE sponsor's.

Independent Physicians and Group Practices

Sales to another physician or physician group are most common in smaller transactions — solo to two-physician, or the addition of a practice to an existing group. These transactions typically produce lower prices (individual physicians don't have PE access to capital) but simpler processes, less documentation burden, and often better cultural fit and autonomy preservation.

Physician buyers usually fund acquisitions through commercial bank loans (SBA 7(a) loans are common for practice acquisitions under $5 million), practice cash flow, or seller financing (a promissory note from the seller). Seller financing is more common than many sellers expect — a buyer who can't get full bank financing may offer a structure where the seller holds a note for 20–30% of the purchase price, paid over three to five years with interest.

Asset Sale vs. Stock Sale: The Tax Implications

The structural decision between an asset sale and a stock sale has significant tax consequences for both parties, and understanding the mechanics before your first negotiation will prevent you from making costly concessions.

Asset sale: The buyer purchases specific assets of the practice (equipment, patient lists, goodwill, contracts, etc.) rather than the legal entity itself. Most buyers prefer asset sales because they get a "stepped-up" tax basis in the acquired assets, meaning they can depreciate them from current fair market value rather than the seller's historical cost basis. This is worth real money over time in depreciation deductions.

Stock sale: The buyer purchases the ownership interest (shares in a corporation, membership interest in an LLC) in the practice entity. The seller typically prefers a stock sale because proceeds are taxed at long-term capital gains rates (currently 20% for high earners, plus 3.8% net investment income tax) rather than a blend of capital gains and ordinary income that often results from an asset sale.

The tax differential can be substantial. On a $4 million transaction, the difference between a fully capital-gains-taxed stock sale and an asset sale with significant ordinary income allocation could easily be $200,000 to $400,000 in after-tax proceeds to the seller.

Eight Factors That Drive a Premium Valuation

Within any specialty's multiple range, your practice's specific characteristics determine where you land. These are the eight factors that consistently move valuations toward the top of the range.

1. Clean financials with an upward trajectory. Three years of audited or reviewed financials with growing collections, stable or improving margins, and no anomalous years (or well-documented explanations for any dips) signals a lower-risk investment to buyers. Collections trending up 5–8% annually are meaningfully more attractive than flat collections.
2. Revenue diversification. A practice with multiple physicians, multiple payers, and multiple revenue streams (professional services plus ancillaries) is less vulnerable to disruption than a solo-physician practice dependent on two insurance contracts. Diversification reduces risk, and risk reduction translates to higher multiples.
3. Favorable payer contracts. If you have negotiated rates materially above Medicare benchmark — and those rates are locked in long-term — that's a transferable asset with real cash flow value. Buyers will model the contract economics carefully.
4. ASC or ancillary ownership. As noted above, ownership of an ambulatory surgery center, imaging center, or laboratory creates a second earnings stream that compounds value. A practice that generates $800,000 in distributions from its ASC ownership stake is materially more valuable than an otherwise identical practice without it.
5. Physician and staff stability. High provider turnover is a red flag. Buyers will examine how long associate physicians have been with the practice, what their contracts look like, and whether they are likely to stay post-closing. A practice where two of four physicians are recent hires without non-solicitation agreements is a risk buyers will price in.
6. Clean compliance history. No unresolved OIG investigations, no recent RAC audit findings, no history of payer recoupment demands. Buyers conduct compliance diligence, and discovered issues create escrow demands or price reductions.
7. Real estate ownership or favorable lease. Owning your practice building gives you a separate asset to sell or lease back, often at a premium. Even without ownership, a long-term lease at below-market rates is a tangible economic benefit. Short leases (under three years remaining) or above-market leases reduce value.
8. Scalable infrastructure. Modern EHR, documented workflows, solid billing infrastructure, and a management team that doesn't depend entirely on the founding physician signals that the practice can grow under new ownership without a major operational rebuild.

Deal Terms Beyond the Purchase Price

First-time sellers often focus almost entirely on the headline purchase price. Experienced advisors will tell you that several other terms can move your actual realized outcome by as much as the purchase price itself.

Post-Closing Employment Terms

Nearly every practice sale requires the selling physician(s) to continue practicing for a period after closing — typically one to three years. The employment agreement terms during this period matter enormously:

• Compensation structure (base salary vs. productivity model with wRVU or collections benchmarks)
• Call obligations and schedule flexibility
• Non-compete geographic scope and duration (typically 25–50 mile radius, two to five years)
• Termination provisions (are you protected if the buyer underperforms?)

Earnout Provisions

Earnouts tie a portion of the purchase price to future performance. A buyer might offer $5 million at close plus an additional $1 million if the practice achieves $3.5 million in collections in each of the next two years. Earnouts benefit buyers (they only pay if performance materializes) and can benefit sellers if they're confident in continued performance. They create risk if the buyer's operational changes affect your ability to hit the metrics — and they often do.

Escrow and Indemnification

Buyers routinely require 10–15% of the purchase price held in escrow for 12–18 months post-closing as security against indemnification claims (undisclosed liabilities, billing compliance issues discovered after closing). Negotiating the escrow amount down, the release timing, and the indemnification cap are meaningful economics.

Accounts Receivable Treatment

Pre-closing A/R may be retained by the seller, purchased by the buyer at a discount, or handled through a transition services agreement. A practice with $400,000 in pre-closing A/R that reverts to the seller has a very different net economic outcome than one where the A/R is purchased at 60 cents on the dollar.

The Sale Process: A 12–24 Month Timeline

Understanding the typical process flow helps you allocate time and avoid the surprise of how long this actually takes.

Mistakes That Kill Deals or Cut Value

These are the errors that experienced advisors see repeatedly.

• Signing an LOI without an advisor. The LOI is where price and structure are set. Sellers who negotiate LOI terms directly with buyers — particularly PE buyers with experienced M&A counsel — routinely leave money on the table or accept unfavorable terms they don't fully understand.
• Not knowing your compliance exposure before buyers do. If a buyer's due diligence team discovers a coding issue or payer overpayment you weren't aware of, it becomes a lever for price reduction or escrow demands. A pre-sale compliance audit gives you time to remediate issues before they become negotiating liabilities.
• Accepting the first offer without creating competition. Running a competitive process — approaching multiple buyers simultaneously through an advisor — is consistently the most effective way to maximize purchase price. Single-buyer processes almost always yield lower prices.
• Not modeling post-close compensation carefully. A physician who takes a $4.5 million offer with below-market employment compensation for three years may net less than one who accepted $3.8 million with above-market employment terms.
• Letting operations slip during the process. Due diligence takes 45–90 days, during which you're still running the practice. Collections that dip during the transaction give buyers grounds to request a price adjustment or a representation that trailing performance holds through closing.
• Underestimating restrictive covenant impact. A 50-mile non-compete that covers your entire market area and runs for three years post-employment may effectively prevent you from continuing to practice locally. Covenant scope deserves the same negotiation attention as purchase price.

Frequently Asked Questions

How do I know if my practice is even worth selling?

Nearly any profitable practice generating more than $600,000–$800,000 in annual collections will attract at least some buyer interest. The question is usually not whether you can sell, but at what price and to whom. A preliminary valuation conversation with a healthcare M&A advisor or valuation firm (expect to spend $5,000–$15,000 for a formal valuation) will give you a realistic range before you invest significant time in a process.

How long does it take to sell a medical practice?

A full sale process — from initial advisor engagement through closing — typically runs 9 to 18 months. The variance is driven by transaction complexity, due diligence findings, the number of buyers in the process, and regulatory approval requirements. Add six to twelve months of preparation before the formal process begins if you want to approach the market in optimal condition.

Do I need a broker or M&A advisor?

For transactions over $2 million in purchase price, yes. A healthcare M&A advisor earns their fee (typically 3–8% of transaction value, sometimes with a minimum retainer) by creating competitive processes, knowing buyer valuations and structures, managing due diligence, and preventing the deal from collapsing. Solo negotiations with institutional buyers without advisor representation consistently produce worse outcomes for sellers.

What happens to my staff when I sell?

This depends on the buyer and the deal terms. Most buyers intend to retain existing staff (their operational knowledge is part of what you're selling), though compensation and benefit structures may change. Employment transition terms — particularly for key staff — are often negotiable in the purchase agreement. For hospital system acquisitions, staff typically transition to health system employment with comparable benefits. For PE transactions, practice staff often remain on the practice's payroll until integration decisions are made.

Can I retain ownership of my building?

Yes — and in many cases this is advantageous. If you own the real estate, selling the practice while retaining building ownership and leasing back to the acquirer creates a separate passive income stream. The lease terms (rate, escalation, duration) become a separate negotiation. Some physicians use a sale-leaseback structure on both the practice and the real estate simultaneously, optimizing tax treatment and cash proceeds from both.

What is a quality of earnings (QoE) report and do I need one?

A quality of earnings report is an independent financial analysis — typically prepared by an accounting firm — that validates the practice's EBITDA claims and identifies any adjustments or anomalies. Buyers for larger transactions ($5 million+) typically require their own QoE. Sellers who commission a sell-side QoE before going to market signal confidence, reduce buyer diligence friction, and speed up closing timelines. For transactions over $3 million, a sell-side QoE typically runs $15,000–$40,000 and is usually worth it.

How are accounts receivable handled at closing?

A/R treatment is negotiated as part of the deal. Common approaches: (1) seller retains all pre-closing A/R collected over a transition period with buyer providing billing services; (2) buyer purchases pre-closing A/R at a discount (typically 50–75 cents on the dollar depending on aging profile); (3) A/R is excluded from the transaction entirely and seller winds down collections independently. Each has different cash flow and tax implications — your advisor should model all three scenarios.

What's the difference between a letter of intent and the purchase agreement?

The LOI (letter of intent) is typically a short (3–8 page) document that outlines the key business terms — purchase price, structure, exclusivity period, and high-level employment terms. Most LOI provisions are non-binding (except exclusivity and confidentiality). The purchase agreement is the binding legal contract, typically 50–150 pages, that governs the actual transaction. The LOI sets the framework; the purchase agreement fills in every detail. Most of the real negotiation happens at the LOI stage and in purchase agreement markups.